Effects of normalization of GH hypersecretion on lipoprotein(a) and other lipoprotein serum levels in acromegaly

Clinical Endocrinology

Volumn 53, Issue 3, 2000, Pages 313-319

  Maldonado Castro, Gonzalo F ^a,b   Escobar Morreale, Héctor F ^a,b   Ortega, Henar ^a,b   Gómez Coronado, Diego ^a,b   Balsa Barro, José A ^a,b   Varela, César ^a,b   Lasunción, Miguel A ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; CABERGOLINE; LIPOPROTEIN; LIPOPROTEIN A; LIPOPROTEIN LIPASE;

ACROMEGALY; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GROWTH HORMONE RELEASE; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; METABOLIC REGULATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ACROMEGALY; ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH HORMONE; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 0033824632     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01092.x     Document Type: Article

References (41)

1. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
2. Effects of octreotide on lipid metabolism in acromegaly
3. Acromegaly
4. Effect of growth hormone on carbohydrate and lipid metabolism
5. Triiodothyronine rapidly lowers plasma lipoprotein(a) in hypothyroid subjects
6. Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp (a) and HDL cholesterol concentrations
7. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
8. Fibrinolytic parameters and lipoprotein(a) levels in plasma of patients with coronary artery disease
9. Polymorphic forms of human apolipoprotein [a]: Inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]
10. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy
11. Lipoprotein(a) changes during growth hormone treatment
12. Short-term growth hormone therapy increases serum lipoprotein(a) levels in normal short children without growth hormone deficiency
13. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias
14. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly
15. Growth hormone increases and insulin like growth factor-1 decreases circulating lipoprotein(a)
16. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and acromegaly
17. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension?
18. Lipoprotein(a) in acromegaly
19. Homeostasis model assesment: Insulin resistance and β-cell function from fasting plasma insulin and glucose concentrations in man
20. Clinical review 75: Recent advances in pathogenesis, diagnosis and management of acromegaly
21. Basal and insulin-stimulated substrate metabolism in patients with acromegaly before and after adenomectomy
22. Acromegaly
23. The effect of recombinant human GH replacement therapy on lipoprotein (a) and other lipid parameters in adults with acquired GH deficiency: Results of a double-blind and placebo controlled trial
24. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment
25. Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I
26. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity
27. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy
28. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins
29. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease
30. Lipoprotein(a): Clinical approach to a unique atherogenic lipoprotein
31. Determinants of clinical outcome and survival in acromegaly
32. Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin growth factor-I
33. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients
34. Effect of postmenopausal estrogen replacement on plasma Lp (a) lipoprotein concentrations
35. Lipoprotein(a) and atherosclerosis
36. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48, apoB 100 synthesis and secretion in the rat liver
37. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women
38. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients
39. The mysteries of Lipoprotein(a)
40. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
41. Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like factor I